Further analysis revealed the cancer specimen was negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2), indicating that the malignancy was triple-negative breast cancer. Here, ESR1 is linked to triple-negative breast carcinoma.